Global Veterinary Antibiotics Market Report 2021: Antiparasitics, Antibacterials, Nonsteroidal Anti-Inflammatory Drugs, Premixes, Injections, Oral Powders, Oral Solutions – ResearchAndMarkets.com | Company
DUBLIN – (BUSINESS WIRE) – August 6, 2021–
the “Global Veterinary Antibiotics Market Report 2021: Impact and Recovery of COVID-19 until 2030” report was added to ResearchAndMarkets.comoffer.
The main players in the veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly Company and Elanco.
The global veterinary antibiotics market is expected to grow from $ 1.12 billion in 2020 to $ 1.22 billion in 2021 at a compound annual growth rate (CAGR) of 8.9%. The growth is mainly due to companies reorganizing their operations and recovering from the impact of COVID-19, which previously led to restrictive containment measures involving social distancing, remote working and the closure of business activities which resulted in operational challenges. The market is expected to reach $ 1.53 billion in 2025 at a CAGR of 5.8%.
The veterinary antibiotics market includes sales of veterinary antibiotics and related services. Veterinary antibiotics are used to fight infections and diseases in animals caused by bacteria. The veterinary antibiotics industry includes companies involved in the production of antibiotics used for the therapeutic and prophylactic treatment of animals.
Growing collaboration between companies is an emerging trend in the veterinary antibiotics market. The collaboration allows companies to combine technologies and a larger and more diverse product portfolio with which to work, and it also improves the quality of antibiotics and the speed at which they produce. Therefore, companies in the veterinary antibiotics market are focusing on collaborations.
The growing threat of antibiotic resistance is a major constraint for the veterinary antibiotics market. Antibiotic resistance in animals is the ability of a microbe to resist the impact of an antibiotic that once could successfully treat infection from the same type of microbe. This may be the result of using antibiotics over the prescribed limit. In this regard, the European Union (EU) has approved various restrictions on veterinary antibiotics, including a ban on antibiotics for animals and a ban on the use of antimicrobials in food, which restricts the growth of the market. veterinary antibiotics.
The prescription drug market for veterinary antibiotics is regulated by Section 503 (f) of the Food, Drug and Cosmetic Act of the FDA. According to this law, the labels of veterinary antibiotic drugs must include a warning that these drugs can only be used with the permission of a licensed veterinarian. The sale and use of prescription antibiotics without a prescription is usually reported to the FDA and strict action is taken accordingly. Therefore, such regulations would regulate manufacturers and sellers of veterinary antibiotics.
The increase in the number of zoonoses is stimulating the market for veterinary antibiotics. Zoonoses are infectious diseases caused by microscopic organisms, infections and parasites that spread between animals and humans. Two of the most common zoonotic pathogens, salmonella and campylobacter, are found in the intestines of these animals. Zoonotic diseases are also a potential threat to humans as they are transferred through the food chain.
Main topics covered:
2. Characteristics of the veterinary antibiotics market
3. Veterinary Antibiotics Market Trends and Strategies
4. Impact of COVID-19 on veterinary antibiotics
5. Size and growth of the veterinary antibiotics market
5.1. Global Historical Veterinary Antibiotics Market, 2015-2020, in USD Billion
5.1.1. Market drivers
5.1.2. Market restrictions
5.2. Global Veterinary Antibiotics Forecast Market, 2020-2025F, 2030F, in USD Billion
5.2.1. Market drivers
5.2.2. Market constraints
6. Segmentation of the veterinary antibiotics market
6.1. Global Veterinary Antibiotics Market, Segmentation by Product, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- Nonsteroidal anti-inflammatory drug
6.2. Global Veterinary Antibiotics Market, Segmentation by End User, History and Forecast, 2015-2020, 2020-2025F, 2030F, Billion USD
- Farm animals
6.3. Global Veterinary Antibiotics Market, Segmentation by Administration, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- Oral powders
- Oral solutions
7. Regional and national analysis of the veterinary antibiotics market
7.1. Global veterinary antibiotics market, divided by region, historical and forecast, 2015-2020, 2020-2025F, 2030F, in USD billion
7.2. Global veterinary antibiotics market, divided by country, historical and forecast, 2015-2020, 2020-2025F, 2030F, in billions of dollars
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Animal Health
- Eli Lilly Company
- Merck & Co
- Cristal Pharma
- Dechra Pharmaceuticals PLC
- Huvepharma AD
- Vétoquinol SA
- Merial (Animal Health Division of Sanofi)
- Novartis Animal Health
- Phibro Animal Health Society
- Bioniche Animal Health
- Fort Dodge Animal Health
- Pfizer Inc
- IDEXX Laboratories
- BioPrédic International
- Sparhawk Laboratories
- Stason Pharmacy
- Vedco Inc
For more information on this report, visit https://www.researchandmarkets.com/r/hbgncp
View source version on businesswire.com:https://www.businesswire.com/news/home/20210806005211/en/
Laura Wood, Senior Press Director
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
INDUSTRY KEYWORD: CONSUMER HEALTH PETS VETERINARY PHARMACEUTICAL
SOURCE: Research and markets
Copyright Business Wire 2021.
PUB: 06.08.2021 06: 32 / DISC: 06.08.2021 06:32